2
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
243
Neoplasms
17
Neoplasm Metastasis
15
Carcinoma, Intraductal, Noninfiltrating
11
Breast Diseases
8
Advanced Breast Cancer
8
Breast Neoplasms, Male
7
Breast Carcinoma In Situ
7
Triple Negative Breast Neoplasms
5
Ovarian Neoplasms
5
Endometrial Neoplasms
5
Arthralgia
5
Neoplasms by Site
3
Breast Cancer Metastatic
3
Uterine Cervical Neoplasms
2
Recurrence
2
Patient Compliance
2
Osteoporosis
2
Obesity
2
Multiple Endocrine Neoplasia Type 1
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasm Female
2
Vitamin D Deficiency
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Skin Diseases
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Seizures
1
Sarcoma
1
Interventions
Exercise
3
Patient Navigation
2
Interviews as Topic
2
Anastrozole
2
regorafenib
1
potassium oxonate
1
beta-Aminoethyl Isothiourea
1
Weights and Measures
1
Videotape Recording
1
Trastuzumab
1
Surveys and Questionnaires
1
Standard of Care
1
Specimen Handling
1
Self Care
1
Radiation
1
Psychosocial Intervention
1
Oxaliplatin
1
Ocoxin
1
Nutrition Assessment
1
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine
1
Motivational Interviewing
1
Metabolism
1
Leuprolide
1
Lapatinib
1
Goserelin
1
Diet Therapy
1
Diet
1
Clodronic Acid
1
Cisplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Patient Compliance
×
Anastrozole
×
Clear all
NCT00936442
2012-02-14
ARTEMIS
AstraZeneca
Completed
104 enrolled
NCT00555867
2011-12-23
PACT
AstraZeneca
Terminated
4,923 enrolled